Urgent coronary artery bypass graft operation of a patient with acute anterior myocardial infarction, congenital right coronary artery to main pulmonary artery fistula and left hilar hamartoma of the lung

Talay, Süreyya; Saracoglu, Tolga; Kabalar, Mehmet Eşref; Kayğın, Mehmet Ali; Erkut, Bilgehan

doi:10.1007/s10353-011-0593-y

Cited by 1 publication

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Symptoms are more likely to manifest in the elderly, and are largely attributable to the blood flow through the shunt and the structures involved (12)(13)(14)(15). CAFs may sometimes cause acute myocardial infarction, which may necessitate coronary artery bypass surgery (7,16). Our patient had no apparent symptoms because there was a minimal shunt from the distal coronary blood flow.…”

Section: Discussionmentioning

confidence: 79%

See 1 more Smart Citation

Coronary artery fistula and lung adenocarcinoma: a case report and literature review

et al. 2021

View full text Add to dashboard Cite

Coronary artery fistula (CAF) is a rare condition, whilst lung cancer is one of the most common malignant tumors worldwide. We came cross an interesting case with both diseases. To the best of our knowledge, this is the first case report pertaining to a patient with a coexisting CAF and lung adenocarcinoma. The patient was a 67-year-old woman who was admitted to our hospital for evaluation of persistent cough. Through the examination she was diagnosed coronary artery fistula and lung adenocarcinoma. Both diseases were successfully treated in a single operation (artery ligation and pulmonary lobectomy). The post-operative period was uneventful. At 3-month follow-up, there were no signs of blood shunting or cancer recurrence. There is no standard guidelines to treat both diseases. We want to seek out a solution to the problem. In this patient, we successfully performed artery ligation and pulmonary lobectomy in a single operation without any complications. We believe the treatment of patients with CAFs should be individualized. But, there is still a lot of shortcomings in our research. First of all, we have no enough cases to support our approach. What's more, the long-term effects of the operation are not certain. Last but not least, we have no proof in genetics with both diseases.

show abstract

Section: Discussionmentioning

confidence: 79%

“…CAFs originating from the LCx account for 18% of cases (4)(5)(6). The flow endpoint of the fistula is in the right ventricle in 40% of cases, right atrium in 25% of cases, PA in 15-20% cases, coronary sinus in 7-10% of cases, and the superior vena cava in 1-2% cases (7).…”

Section: Discussionmentioning

confidence: 99%